Down-regulation of RNA editing of GLI1 in tumors and analysis of its potential function

ZHANG Ying,HU Ya-ou,HE Tao,HOU Xiao-qiang,WANG Li,ZHANG Bu-chang,WANG Yu-min

DOI: https://doi.org/10.3969/j.issn.1674-9960.2012.04.007

2012-01-01

Abstract:Objective To detect the A-to-I RNA editing in the coding region of cancer associated gene GLI1,compare the difference in the editing level between tumor and normal cell lines,and to analyze the potential effect of this editing event in the hope of discovering the role of the RNA editing in the occurrence and progression of cancer.Methods The identification of the A-to-I RNA editing event and the comparison of the editing level were carried out by comparing the cDNA sequences with their corresponding genomic templates based on PCR,RT-PCR and sequencing methods.The potential functional implications of RNA editing were analyzed by multiple bioinformatics tools.Results An A-to-I RNA editing site mapped to chr 12∶56150891 changed the arginine residue at position 701 of the GLI1 protein to a glutamine residue,which was detected in the human brain,breast,small intestine tissues and multiple cell lines.Compared with normal controls,the editing level of this site decreased in the hepatoma and breast cancer cell lines.By bioinformatics analysis,this editing event altered amino acid residue and was predicted to destroy putative exonic splicing enhancers(ESE) and affect putative protein tertiary structure.Conclusion This A-to-I RNA editing event in the coding region of GLI1 occurs in many diverse human tissues and cell lines.Down-regulation of RNA editing of GLI1 in hepatoma and breast cancer cell lines may be associated with the occurrence and progression of cancer.